|
注册号: Registration number: |
ChiCTR2200055653 |
|
最近更新日期: Date of Last Refreshed on: |
2023-07-16 20:01:17 |
|
注册时间: Date of Registration: |
2022-01-15 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
深圳-伦敦卒中急救体系在急性脑血管病患者救治中的对照研究 |
|
Public title: |
The emergency management of patients with acute ischemic stroke in Shenzhen and London: a comparative study |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
深圳-伦敦卒中急救体系在急性脑血管病患者救治中的对照研究 |
|
Scientific title: |
The emergency management of patients with acute ischemic stroke in Shenzhen and London: a comparative study |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
胡诗雨 |
研究负责人: |
任力杰 |
|
Applicant: |
Shiyu Hu |
Study leader: |
Lijie Ren |
|
申请注册联系人电话: Applicant telephone: |
+86 15007553360 |
研究负责人电话:
Study leader's |
+86 13631605966 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
15007553360@163.com |
研究负责人电子邮件: Study leader's E-mail: |
13631605966@126.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
广东省深圳市福田区笋岗西路3002号 |
研究负责人通讯地址: |
广东省深圳市福田区笋岗西路3002号 |
|
Applicant address: |
3002 Sungang Road West, Futian District, Shenzhen, Guangdong |
Study leader's address: |
3002 Sungang Road West, Futian District, Shenzhen, Guangdong |
|
申请注册联系人邮政编码: Applicant postcode: |
518000 |
研究负责人邮政编码: Study leader's postcode: |
518000 |
|
申请人所在单位: |
深圳市第二人民医院 |
||
|
Applicant's institution: |
Shenzhen Second People's Hospital |
||
|
研究负责人所在单位: |
深圳市第二人民医院 |
||
|
Affiliation of the Leader: |
Shenzhen Second People's Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
20211011010-FS01 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
深圳市第二人民医院临床科研伦理委员会 |
||
|
Name of the ethic committee: |
Clinical Research Ethics Committee of Shenzhen Second People's Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2021-11-24 00:00:00 | ||
|
伦理委员会联系人: |
陈旭虹 |
||
|
Contact Name of the ethic committee: |
Xuhong Chen |
||
|
伦理委员会联系地址: |
广东省深圳市福田区笋岗西路3002号 |
||
|
Contact Address of the ethic committee: |
3002 Sungang Road West, Futian District, Shenzhen, Guangdong |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
深圳市第二人民医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Shenzhen Second People's Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
广东省深圳市福田区笋岗西路3002号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
3002 Sungang Road West, Futian District, Shenzhen, Guangdong |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
深圳市科技创新委员会 |
||||||||||||||||||||||
|
Source(s) of funding: |
Shenzhen Municipal Commission of Science and Technology Innovation |
||||||||||||||||||||||
|
研究疾病: |
急性脑血管病 |
||||||||||||||||||||||
|
Target disease: |
Acute ischemic stroke |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
非随机对照试验 |
||||||||||||||||||||||
|
Study design: |
Non randomized control |
||||||||||||||||||||||
|
研究目的: |
本研究拟通过评价伦敦救治系统及深圳救治系统下的缺血性卒中患者的急性期救治指标,包括目前公认的静脉溶栓率、Door to Needle Time(DNT)、Onset to Needle Time (ONT)等,从而比较两种卒中急救体系的在急性缺血性脑卒中患者救治中的差异,以此完善卒中急救体系,以利于其推广应用。 |
||||||||||||||||||||||
|
Objectives of Study: |
This study intends to compare the two strokes by evaluating the acute phase treatment indicators of ischemic stroke patients under the London treatment system and the Shenzhen treatment system, including the currently recognized intravenous thrombolysis rate, Door to Needle Time (DNT), Onset to Needle Time (ONT), etc. The first aid system differs in the treatment of patients with acute ischemic stroke, so as to improve the stroke emergency system and facilitate its popularization and application. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1. 无症状及体征的静止性脑梗死; |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Silent cerebral infarction without symptoms and signs; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2022-01-01 00:00:00至 To 2023-06-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2022-01-01 00:00:00 至 To 2022-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男性 |
Gender: |
Male |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
N/A |
|
Blinding: |
N/A |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
不享用原始数据 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Not sharing |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
电子病历系统 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Computer-based Patient Record |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |